Screener
Chemours CC Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $671M+33.7% | $563M+21.3% | $670M-6.0% | $613M+2.9% | $502M-16.9% | ||
| $907M-5.4% | $759M-11.5% | $679M-11.8% | $947M-0.4% | $959M+5.8% | ||
| $1.45B-6.8% | $1.54B-0.9% | $1.57B+7.2% | $1.55B+7.9% | $1.56B+14.6% | ||
| $3.09B-0.2% | $2.93B-0.2% | $3B-0.5% | $3.21B+4.3% | $3.1B+5.5% | ||
| $3.03B-3.2% | $3.04B-3.1% | $3.08B-3.5% | $3.1B-2.3% | $3.13B-0.7% | ||
| $46M0.0% | $46M0.0% | $46M0.0% | $46M0.0% | $46M-54.9% | ||
| $2M0.0% | $2M0.0% | $2M-33.3% | $2M-33.3% | $2M-33.3% | ||
| $7.15B-4.2% | $7.27B-1.5% | $7.38B-1.7% | $7.55B+1.2% | $7.46B+3.0% | ||
| $937M-8.4% | $891M-11.4% | $954M-17.5% | $1.04B-4.0% | $1.02B+8.7% | ||
| $34M-10.5% | $37M-14.0% | $42M-22.2% | $52M-1.9% | $38M+2.7% | ||
| $1.86B+1.9% | $1.61B-3.5% | $1.69B-7.4% | $1.87B+4.8% | $1.83B+17.1% | ||
| $3.84B-6.6% | $4.1B+0.8% | $4.1B+1.0% | $4.1B+2.9% | $4.11B+3.9% | ||
| $7.2B-0.5% | $7.05B+3.6% | $7.13B+2.8% | $7.27B+6.7% | $7.23B+10.8% | ||
| $2M0.0% | $2M0.0% | $2M0.0% | $2M0.0% | $2M0.0% | ||
| $891M-28.7% | $1.18B-28.3% | $1.22B-27.6% | $1.28B-26.7% | $1.25B-31.3% | ||
| -$49M-121% | $215M-62.0% | $250M-56.2% | $274M-57.4% | $228M-68.1% | ||
| $7.15B-4.2% | $7.27B-1.5% | $7.38B-1.7% | $7.55B+1.2% | $7.46B+3.0% |
FAQ
- What are Chemours's total assets?
- Chemours (CC) holds $7.2B in total assets, down 4.2% year over year.
- How much debt does Chemours have?
- Chemours carries $4.2B in total debt against -$49.0M of shareholders' equity, a debt-to-equity ratio of 20.59.
- How much cash does Chemours have?
- Chemours holds $671.0M in cash and equivalents.
- Can Chemours cover its short-term obligations?
- Its current ratio is 1.66 — current assets exceed current liabilities.
- Where does Chemours's balance sheet data come from?
- Every line is extracted from Chemours's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
